author-photo

Candice Junge

Baxter International

14

Papers

364

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients with Left Ventricular Dysfunction Post STEMI.

2017 Circulation Research
Show All
- Source
- Cite
- Save
Citations (90)
Autologous CD34+ cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study

2016 Cell Transplantation
Show All
- Source
- Cite
- Save
Citations (45)
IMPACT OF MOBILIZATION ABILITY ON CELL FUNCTIONALITY AND COMPARISON OF NORMAL AND CMI SUBJECT SAMPLES: AN ANALYSIS FROM ACT34–CMI

2013 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (1)
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous cd34+ cell administration in patients with refractory angina: Design of the renew study

2013 American Heart Journal
Show All
- Source
- Cite
- Save
Citations (74)
Abstract 12015: Clinical Parameters Influencing Cell Mobilization and Impact of Mobilization Ability on Efficacy Outcomes: An Analysis from ACT34-CMI

2012 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia

2012 Circulation-cardiovascular Interventions
Show All
- Source
- Cite
- Save
Citations (137)
Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI

2012 American Heart Journal
Show All
- Source
- Cite
- Save
Citations (14)
Abstract 11777: A Phase 3, Randomized, Partially Blinded, Active-Controlled, Study Assessing the Efficacy and Safety of Intramyocardial Autologous CD34+ Cell Administration in Patients with Refractory Angina: Design of the RENEW Study

2012 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 11770: Cardiac Biomarker Elevation during Stem Cell Mobilisation, Apheresis and Intramyocardial Delivery is Common but does not Impact Incidence of Long-Term MACE: An Analysis from ACT34-CMI

2012 Circulation
Show All
- Source
- Cite
- Save
Citations (1)